Search results
Elon Musk’s X can’t invent its own copyright law, judge says
Ars Technica· 5 days agoUS District Judge William Alsup has dismissed Elon Musk's X Corp lawsuit against Bright Data, a...
The 15 best pool lounge chairs, according to design experts | CNN Underscored
CNN.com· 10 hours agoEven if you’re deep in suburbia, hundreds of miles from the nearest ocean, the best pool lounge...
Social media companies ask judge to strike youth addiction lawsuit filed by school districts
Courthouse News Service· 2 days agoLawyers for the biggest social media companies in the world appeared in court on Monday to ask a Los...
Lument Finance Trust Reports First Quarter 2024 Results
Rome Sentinel· 6 days agoLument Finance Trust, Inc. (NYSE: LFT) ("we", "LFT" or "the Company") today reported its first quarter results. Distributable earnings for the first quarter were $7.6 million, or $0.15 per share ...
Q1 2024 Profire Energy Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 6 days agoThe industry was also impacted by the over $230 billion spend on mergers and acquisitions from crude oil and natural gas exploration and production companies. Despite these ...
Securities Act Rule 192 – Conflicts of interest relating to certain securitizations | JD Supra
JD Supra· 6 days agoThis rule represents the culmination of the efforts of the Securities and Exchange Commission (“SEC”) to adopt a rule on conflicts of interest relating to securitization (“Rule 192”) to implement ...
Earnings call: Fate Therapeutics reports on clinical progress and finances By Investing.com
Investing.com· 2 days agoIn the recent earnings call, Fate Therapeutics (Ticker: NASDAQ:FATE) highlighted significant...
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 days agoANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q1 2024 Earnings Call Transcript May 10, 2024 ANI...
Earnings call: 2seventy bio eyes growth with focus on Abecma in Q1 2024 By Investing.com
Investing.com· 6 days ago2seventy bio (Ticker: TSVB) reported its financial results and business updates during its First...
Earnings call: Fate Therapeutics reports on clinical progress and finances
Investing.com· 3 days agoIn the recent earnings call, Fate Therapeutics (Ticker: NASDAQ: FATE ) highlighted significant...
